Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib/Phase II Trial With Capivasertib Plus Immunotherapy in Bladder Cancer

NCT07793578 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT07793578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07793578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib/Phase II Trial With Capivasertib Plus Immunotherapy in Bladder Cancer
Lead sponsor
VA Office of Research and Development
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
January 1, 2027
Completion date
September 30, 2030
Enrollment
32 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

advanced urothelial carcinoma